Showing results (311-320 of 607) with videos related to

Sort By:
Pageof 61
FEBS Letters|February 2, 2010
Intrahepatic cholesterol influences progression, inhibition and reversal of non-alcoholic steatohepatitis in hyperlipidemic miceKristiaan Wouters, Marc van Bilsen, Patrick J van Gorp, et al.
Biochimica Et Biophysica Acta|November 22, 2005
Fenofibrate reverses the decline in HDL cholesterol in mice overexpressing human phospholipid transfer proteinJessica Lie, Inge M Lankhuizen, Barbara Gross, et al.
Environment International|October 13, 2025
Human liver perfluorooctane sulfonate associates with steatotic liver disease in a sex-dependent mannerEmily Flam, Viktor Liénard, Violeta Raverdy, et al.
Gastroenterology|June 14, 2003
FXR induces the UGT2B4 enzyme in hepatocytes: a potential mechanism of negative feedback control of FXR activityOlivier Barbier, Ines Pineda Torra, Audrey Sirvent, et al.
International Journal of Cardiology|August 6, 2018
Peri-operative acute kidney injury upon cardiac surgery time-of-daySandro Ninni, Claire Seunes, Staniel Ortmans, et al.
Molecular and Cellular Biology|April 14, 2010
Kruppel-like factor KLF10 is a link between the circadian clock and metabolism in liverFabienne Guillaumond, Aline Gréchez-Cassiau, Malayannan Subramaniam, et al.
Molecular and Cellular Biology|April 1, 2015
Modulation of Macrophage Gene Expression via Liver X Receptor α Serine 198 PhosphorylationChaowei Wu, Maryem A Hussein, Elina Shrestha, et al.
Biochemical Pharmacology|January 4, 2005
Pro-inflammatory properties for thiazolidinedionesChristophe Desmet, Barbara Warzée, Philippe Gosset, et al.
Bioorganic & Medicinal Chemistry|December 4, 2021
Synthesis and biological studies of "Polycerasoidol" and "trans-δ-Tocotrienolic acid" derivatives as PPARα and/or PPARγ agonistsLaura Vila, Nuria Cabedo, Carlos Villarroel-Vicente, et al.
Pageof 61